Exact Mass: 353.1586778
Exact Mass Matches: 353.1586778
Found 131 metabolites which its exact mass value is equals to given mass value 353.1586778,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Olopatadine n-oxide
3-[(2Z)-5-(carboxymethyl)-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-2-ylidene]-N,N-dimethylpropanamine oxide
Olopatadine n-oxide is a metabolite of olopatadine. Olopatadine hydrochloride is an antihistamine (as well as anticholinergic) and mast cell stabilizer, sold as a prescription eye drop (0.2\\% solution, Pataday, manufactured by Alcon). It is used to treat itching associated with allergic conjunctivitis. Olopatadine hydrochloride 0.1\\% is sold as Patanol (or Opatanol in some countries). A nasal spray formulation is sold as Patanase, which was approved by the FDA on April 15, 2008. (Wikipedia)
4-(4-(4-Fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine
4-(4-(4-Fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine
Dihydropalmatine
2,3,9,10-tetramethoxy-6,8-dihydro-5H-isoquinolino[2,1-b]isoquinoline
Dihydropalmatine is a natural product found in Thalictrum foliolosum with data available. Dihydropalmatine is a alkaloid isolated from Berberis aristata[1].
Dehydroglaucine
4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,3,5,7,9(17),13,15-heptaene
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.323 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.326 Dehydroglaucine is a natural product found in Sarcocapnos saetabensis, Thalictrum ichangense, and other organisms with data available.
4-Hydroxy-5,8-dimethoxy-2-(3-methoxyphenyl)-3-propylquinoline
4-Hydroxy-5,8-dimethoxy-2-(3-methoxyphenyl)-3-propylquinoline
8-Methoxy-uvariopsin|8-Methoxyuvariopsine|[2-(8,9-Dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-aethyl]-dimethyl-amin|[2-(8,9-dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-ethyl]-dimethyl-amine
8-Methoxy-uvariopsin|8-Methoxyuvariopsine|[2-(8,9-Dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-aethyl]-dimethyl-amin|[2-(8,9-dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-ethyl]-dimethyl-amine
2,3-Dihydrocapitavine|dihydroxy-5,7 (methyl-1 piperidinyl-2)-6 flavanone
2,3-Dihydrocapitavine|dihydroxy-5,7 (methyl-1 piperidinyl-2)-6 flavanone
5,8-dimethoxy-2-(3-methoxyphenyl)-3-propyl-1h-quinolin-4-one
5,8-dimethoxy-2-(3-methoxyphenyl)-3-propyl-1h-quinolin-4-one
Fmoc-Leu-OH
N- (9-FLUORENYLMETHOXYCARBONYL)-L-LEUCINE
Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity[1].
3-[3-(4-tert-butylphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid
3-[3-(4-tert-butylphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid
tert-Butyl (2S,3R)-(+)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate
tert-Butyl (2S,3R)-(+)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate
[4-(4-fluoro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid
[4-(4-fluoro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid
2-(trifluoromethyl)--1H-Pyrrolo[2,3-b]pyridin-5-amine
2-(trifluoromethyl)--1H-Pyrrolo[2,3-b]pyridin-5-amine
1-benzyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydropyridin-4-one
1-benzyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydropyridin-4-one
Benzoicacid, 2-[4-(cyclohexylmethylamino)-2-hydroxybenzoyl]-
Benzoicacid, 2-[4-(cyclohexylmethylamino)-2-hydroxybenzoyl]-
TERT-BUTYL 4-(BENZYLOXY)-3-(HYDROXYMETHYL)-1H-INDOLE-1-CARBOXYLATE
TERT-BUTYL 4-(BENZYLOXY)-3-(HYDROXYMETHYL)-1H-INDOLE-1-CARBOXYLATE
Tert-butyl-(2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate
Tert-butyl-(2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate
N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C
N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C
NS-11394
NS-11394
NS11394 is an orally active and unique subtype-selective GABAA positive allosteric receptor (PAM), with a Ki of ~0.5 nM. NS11394 shows a selectivity profile in the order of GABAA-5 > α3 > α2 > α1-containing receptors. NS11394 has anxiolytic and anti-inflammatory properties[1][2][3].
Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone
Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone
3-[(2E,4E)-4,6-dimethylocta-2,4-dienoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1H-pyridin-2-one
3-[(2E,4E)-4,6-dimethylocta-2,4-dienoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1H-pyridin-2-one
2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid
2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid
2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-hydroxyanilino)-5-pyrimidinecarboxylic acid ethyl ester
2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-hydroxyanilino)-5-pyrimidinecarboxylic acid ethyl ester
2-(1,2-Dihydroimidazo[1,2-a]benzimidazol-4-yl)-1-(4-phenylphenyl)ethanone
2-(1,2-Dihydroimidazo[1,2-a]benzimidazol-4-yl)-1-(4-phenylphenyl)ethanone
4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione
4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione
2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide
2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide
1-[(1-tert-butyl-5-tetrazolyl)-thiophen-2-ylmethyl]-3,4-dihydro-2H-quinoline
1-[(1-tert-butyl-5-tetrazolyl)-thiophen-2-ylmethyl]-3,4-dihydro-2H-quinoline
N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]heptanediamide
N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]heptanediamide
N-[(4-methylphenyl)methyl]-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine
N-[(4-methylphenyl)methyl]-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine
N-Pyridin-2-yl-3-(o-tolylaminooxalyl-hydrazono)-butyramide
N-Pyridin-2-yl-3-(o-tolylaminooxalyl-hydrazono)-butyramide
(E)-2-cyano-3-[2-(2,6-dimethylmorpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide
(E)-2-cyano-3-[2-(2,6-dimethylmorpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide
4-[(5-Methyl-2,4-diphenyl-2H-pyrazol-3-ylimino)-methyl]-phenol
4-[(5-Methyl-2,4-diphenyl-2H-pyrazol-3-ylimino)-methyl]-phenol
4-[2-[[1-(Phenylmethyl)-2-benzimidazolyl]thio]ethyl]morpholine
4-[2-[[1-(Phenylmethyl)-2-benzimidazolyl]thio]ethyl]morpholine
ESI-08
ESI-08
ESI-08 is a potent and selective EPAC antagonist, which can completely inhibit both EPAC1 and EPAC2 (IC50 of 8.4 μM) activity. ESI-08 selectively blocks cAMP-induced EPAC activation, but does not inhibit cAMP-mediated PKA activation[1].
FATP1-IN-2
FATP1-IN-2
FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 (FATP1) inhibitor (human IC50=0.43 μM, mouse IC50=0.39 μM)[1].
(9ar)-3-hexanoyl-9a-methyl-6-[(1e)-prop-1-en-1-yl]-7h-furo[3,2-g]isoquinoline-2,9-dione
(9ar)-3-hexanoyl-9a-methyl-6-[(1e)-prop-1-en-1-yl]-7h-furo[3,2-g]isoquinoline-2,9-dione
1-(1,2-dihydroxypropyl)-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione
1-(1,2-dihydroxypropyl)-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione
(12s,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene
(12s,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene
16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene
16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene
3-(1-hydroxyhexylidene)-9a-methyl-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinoline-2,9-dione
3-(1-hydroxyhexylidene)-9a-methyl-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinoline-2,9-dione
(12r,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene
(12r,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene
3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol
3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol
7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid
7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid
(3e)-5-{2,6-dimethyl-5-oxopyrano[3,2-c]quinolin-2-yl}-2,2-dimethylpent-3-enoic acid
(3e)-5-{2,6-dimethyl-5-oxopyrano[3,2-c]quinolin-2-yl}-2,2-dimethylpent-3-enoic acid
3-hexanoyl-9a-methyl-6-(prop-1-en-1-yl)-7h-furo[3,2-g]isoquinoline-2,9-dione
3-hexanoyl-9a-methyl-6-(prop-1-en-1-yl)-7h-furo[3,2-g]isoquinoline-2,9-dione
(2e,4z,6e)-7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid
(2e,4z,6e)-7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid
(3s,4s)-3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol
(3s,4s)-3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol
(2e,4e,6r)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one
(2e,4e,6r)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one
2,3,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene
2,3,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene
(2s)-5-hydroxy-4-[(2e,4e,6e)-1-hydroxy-2,6-dimethylocta-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one
(2s)-5-hydroxy-4-[(2e,4e,6e)-1-hydroxy-2,6-dimethylocta-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one
1-[(1s,2r)-1,2-dihydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione
1-[(1s,2r)-1,2-dihydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione
(1s,21r)-16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene
(1s,21r)-16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene
4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene
4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene
1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one
1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one
3-(1-hydroxyhexylidene)-9a-methyl-6-(prop-1-en-1-yl)furo[3,2-g]isoquinoline-2,9-dione
3-(1-hydroxyhexylidene)-9a-methyl-6-(prop-1-en-1-yl)furo[3,2-g]isoquinoline-2,9-dione
(9s)-4,16-dimethoxy-10-(prop-2-en-1-yl)-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-5,15-diol
(9s)-4,16-dimethoxy-10-(prop-2-en-1-yl)-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-5,15-diol
(2-{1,2-dimethoxy-9h-phenanthro[2,3-d][1,3]dioxol-4-yl}ethyl)dimethylamine
(2-{1,2-dimethoxy-9h-phenanthro[2,3-d][1,3]dioxol-4-yl}ethyl)dimethylamine
3,4,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene
3,4,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene
